Oncurious NV is a Belgium-based biotech company focused on developing innovative oncology treatments derived from a series of promising new targets that are designed to enhance T cell activity, migration and influx into resistant tumor sites, boosting the patient’s own immune response against cancer. The company's lead immuno-oncology asset is a Treg-depleting asset, targeting a protein specifically expressed on Tregs in the tumor microenvironment. The program is in lead optimization. The company's two other programs are focused on T cell migration and are in the discovery stages.
Company Details
- Founded
- 2015
- Address
- Leuven
- Phone
- +32 16 75 13 10
- in****@****ous.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- oncurious.com
- HQ
- Leuven
Oncurious Nv Questions
Oncurious Nv's helpline number is +32 16 75 13 10
Oncurious Nv's website is oncurious.com
Oncurious Nv's LinkedIn profile is https://be.linkedin.com/company/oncurious
Oncurious Nv's industry is
Pharmaceutical Manufacturing
Oncurious Nv's top competitors are
Medvia,
Biovia,
Augustine Therapeutics,
V-Bio Ventures,
Exevir,
Romed Nv,
Biospx Bv,
Belgian Immunological Society Vzw,
Biotope By Vib,
Confo Therapeutics.
Oncurious Nv's support email address is info@oncurious.com
Oncurious Nv's categories are Pharmaceutical Manufacturing
Oncurious Nv's founding year is 2015
